<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 5 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Open Sans";
panose-1:2 11 6 6 3 5 4 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.DefaultFontHxMailStyle
{mso-style-name:"Default Font HxMail Style";
font-family:"Arial",sans-serif;
color:windowtext;
font-weight:normal;
font-style:normal;
text-decoration:none none;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style></head><body lang=EN-CA link=blue vlink="#954F72" style='word-wrap:break-word'><div class=WordSection1><p class=MsoNormal><span class=DefaultFontHxMailStyle>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle> See below for the April e-newsletter from Prostate Cancer Support Regina.<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle>There are several interesting articles.<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle>Take care & stay well.<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle>Glen<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p><p class=MsoNormal>Sent from <a href="https://go.microsoft.com/fwlink/?LinkId=550986">Mail</a> for Windows</p><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p><div style='mso-element:para-border-div;border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal style='border:none;padding:0cm'><b>From: </b><a href="mailto:pccn.regina@gmail.com">Regina Prostate Cancer Support Group Inc.</a><br><b>Sent: </b>April 8, 2022 9:46 PM<br><b>To: </b><a href="mailto:glen.tolhurst@sympatico.ca">glen.tolhurst@sympatico.ca</a><br><b>Subject: </b>April 2022 Newsletter</p></div><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td width="100%" valign=top style='width:100.0%;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='background:#F8F8F8;padding:7.5pt 0cm 7.5pt 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='max-width:450.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt'><p class=MsoNormal align=center style='text-align:center'><img border=0 width=428 height=245 style='width:4.4583in;height:2.552in' id="_x0000_i1041" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/c8faf7db-ef46-e98e-0042-ba04f314e37f.png"><o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr><tr><td valign=top style='background:white;padding:27.0pt 0cm 40.5pt 0cm;background:cover;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;background-size: cover;background-position-x:50%;background-position-y:50%' id=templateBody><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='max-width:450.0pt;border-collapse:collapse;background:#transparent none no-repeat center/cover;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;background-color:#transparent;background-size: cover;background-position-x:50%;background-position-y:50%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td width=300 valign=top style='width:225.0pt;padding:0cm 0cm 0cm 0cm'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='max-width:225.0pt;border-collapse:collapse'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:125%'><span style='font-size:10.5pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'>PCCN-Regina has been rebranded as </span><strong><u><span style='font-size:10.5pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#1C557C'>PROSTATE CANCER SUPPORT - REGIN</span></u></strong><strong><u><span style='font-size:10.5pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'>A </span></u></strong><span style='font-size:10.5pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'>under the Prostate Cancer Support Canada banner sponsored by The Prostate Cancer Foundation of BC.</span><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#1C557C'>The purpose of Prostate Cancer Support - Regina is:</span></strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><br><br>1. To increase awareness, knowledge and understanding<br>about prostate cancer in the community we serve.<br><br>2. To arrange and conduct<br>regular monthly meetings.<br><br>3. To provide education sessions and information to prostate<br>cancer survivors, their families, friends, and the public.<br><br>4. To provide for sharing of experiences and concerns.<br><br>5. To provide counseling services<br>these counseling services do not include recommendations for treatments, medicines or physicians.<br><br>6. To promote courage and hope.<br><br>7. To co-operate with other cancer<br>agencies in the fight against cancer.<br><br></span><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><img border=0 width=200 height=216 style='width:2.0833in;height:2.25in' id="_x0000_i1040" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/89a87179-eec6-6dca-8917-cb88320fd957.png"></span><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td><td width=300 valign=top style='width:225.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='max-width:225.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal align=center style='text-align:center;line-height:125%'><strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#1C557C'>Our next</span></strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><br></span><strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#1C557C'>“Virtual” Meeting is on</span></strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><br></span><strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#1C557C'>Thursday, April 14th, 2022</span></strong><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><br><br><strong><span style='font-family:"Open Sans",sans-serif'>Program:</span></strong><br>Androgen Deprivation Therapy (ADT) <br><br><strong><span style='font-family:"Open Sans",sans-serif'>Presenter:</span></strong><br>23-minute video by Dr.Shreyas Lingadadhai on ADT followed with a representative from the Saskatchewan Cancer Agency working at the Allan Blair Cancer Centre for the post video discussion in the Q&A portion of the meeting.<br><br><strong><span style='font-family:"Open Sans",sans-serif'>Login Details:</span></strong><br>6:15pm: Registration & Test Log In<br><br>6:30pm - 7:30pm: <br>Presentation and Q&A<br><br>7:30pm - 8:30pm: <br>Members Open Forum<br><br><strong><span style='font-family:"Open Sans",sans-serif'>Zoom Meeting Link:</span></strong><br><a href="https://gmail.us20.list-manage.com/track/click?u=d2dc0c23f83844a390026ba8c&id=38f70b85cf&e=4b96d7f66f" target="_blank"><span style='color:#1C557C'>https://us06web.zoom.us/j/82935990734?pwd=bEFZYWNNSmhGY2pNTWVkV0hWbWhLQT09</span></a><br><br>Meeting ID: 829 3599 0734<br>Passcode: 646130<br><br>Find your local number: <a href="https://gmail.us20.list-manage.com/track/click?u=d2dc0c23f83844a390026ba8c&id=26947f3a66&e=4b96d7f66f" target="_blank"><span style='color:#1C557C'>https://zoom.us/u/adQW7reNxv</span></a><br></span><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><img border=0 width=100 height=40 style='width:1.0416in;height:.4166in' id="_x0000_i1039" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/fb0b7add-938e-462a-b2a9-ca5fe2acfa0c.png"></span><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><br><br></span><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><img border=0 width=300 height=158 style='width:3.125in;height:1.6458in' id="_x0000_i1038" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/defe3467-a2bd-fcf4-7993-dbe1c3ff61b1.jpg"></span><span style='font-size:12.0pt;line-height:125%;font-family:"Open Sans",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 0cm 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>If you or someone you know has been affected by PCa and are looking for support and/or information we can still be reached through one of the following options.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575;background:yellow'>New Email:</span><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'> <a href="mailto:info@pccnregina.ca?subject=PCS%20Regina" target="_blank"><span style='color:#1C557C'>i</span></a><a href="mailto:info@pccnregina.ca?subject=PCS%20Regina"><span style='color:#1C557C'>nfo@pccnregina.ca</span></a><br><br>Website: <a href="https://gmail.us20.list-manage.com/track/click?u=d2dc0c23f83844a390026ba8c&id=17442a877e&e=4b96d7f66f" target="_blank"><span style='color:#1C557C'>www.pccnregina.ca</span></a><br><br>Phone: 306-543-8215 </span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:14.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#1D567A'>Presenter Biography</span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'><img border=0 width=200 height=187 style='width:2.0833in;height:1.9479in' id="_x0000_i1037" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/09ab1d80-b955-9f62-bf75-24b16c8976cd.jpg"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Dr. Lingadadhali is a Postdoctoral Fellow at the University of British Columbia and a non-practicing clinical researcher at the Vancouver Prostate Centre, located at the Vancouver General Hospital. Working with a multidisciplinary team of scientists, clinicians, and computational biologists, Dr. Lingadadhali presents on new prostate cancer therapies.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=500 height=80 style='width:5.2083in;height:.8333in' id="_x0000_i1036" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/891338e5-454e-f85f-17f0-ac0df64f5367.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Monthly programs are being developed for the 2022-2023 term. We would appreciate your help with suggesting topics and/or presenters for 2022-2023.<br><br>Please send your suggestions to <a href="mailto:info@pccnregina.ca?subject=Monthly%20Program%20suggestions" target="_blank"><span style='color:#1C557C'>info@pccnregina.ca</span></a> or call any listed Monthly Program board member. </span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=500 height=80 style='width:5.2083in;height:.8333in' id="_x0000_i1035" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/81546dc0-efa0-be05-873c-1183696bcba8.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><strong><span style='font-size:14.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#1D567A'>The Future of Focal Therapy for Prostate Cancer Treatment</span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>The outcomes for patients diagnosed with prostate cancer depend on more than just rates of cure or survival. A considerable burden is experienced by men who require treatment for prostate cancer, in many cases arising from complications of the procedures themselves.<br><br>Many men who undergo surgery or radiation therapy have worse urinary, bowel (respectively) and erectile function after treatment than they did before, which can have a substantial negative effect on their mental health. Refinement of treatment approaches to prostate cancer have drastically improved survival over the past 20-30 years, but this has come with the cost of long-term morbidity for many men. Some innovations in prostate cancer care during this time have had little, if any, effect on postoperative complications (including the use of robotics).<br><br>With advanced medical imaging techniques, such as multiparametric MRI, specific targeting of prostate cancer tumours has become possible. Focal therapy, in which targeted ablation of only cancerous tissue is achieved (using, for example, high-intensity focused ultrasound, cryotherapy, or laser), offers the possibility of good outcomes in terms of metastasis- and cancer-free survival, and avoidance of treatment complications, in men with low or intermediate stage localised prostate cancer.<br><br>In contrast to worsening urinary symptoms and erectile dysfunction after prostatectomy, focal therapy appears to preserve these functions in men, for years after treatment. Critically, focal therapy looks to be as effective, for at least eight years, as prostatectomy, for treating prostate cancer.<br><br>Unfortunately, there are currently no data available from randomised trials of focal therapy versus prostatectomy to guide practice; these will come soon, from at least three prospective clinical trials. Until then, patients should be encouraged by the continuing advances in prostate cancer treatment, and the potential of good long-term treatment outcomes from the point of view of survival and quality of life.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Source: <a href="https://gmail.us20.list-manage.com/track/click?u=d2dc0c23f83844a390026ba8c&id=9a65bfc2bc&e=4b96d7f66f" target="_blank"><span style='color:#1C557C'>https://www.healthymale.org.au/news/future-focal-therapy-prostate-cancer-treatment</span></a></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=500 height=80 style='width:5.2083in;height:.8333in' id="_x0000_i1034" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/81546dc0-efa0-be05-873c-1183696bcba8.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><strong><span style='font-size:14.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#1D567A'>Bipolar Androgen Therapy and the Immune System</span></strong><b><span style='font-size:14.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#1D567A'><br><strong><span style='font-family:"Open Sans",sans-serif'>Part 3: The Potential of Combination Therapy</span></strong></span></b><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Some men are exceptional responders to Bipolar Androgen Therapy (BAT). Its pioneer, medical oncologist Samuel Denmeade, M.D., Co-Director of the Johns Hopkins Prostate Cancer Program, has a few patients who have remained on BAT alone for several years. But for many men, the response is temporary; just a few months. Why? Could it have something to do with mutated genes? What about the immune system?<br><br>“One of the things observed in the lab by our colleague Dr. Sushant Kachhap is that when we give testosterone, the prostate cancer cells get stressed and turn on all these immune factors,” says Denmeade. “Testosterone activates immune pathways.” When three men who had participated in BAT trials later had “dramatic” responses to immunotherapy – 100-percent decreases in PSA, and one man remains in long-term remission – “we thought that might be the secret: androgen plus immunotherapy.”<br><br>COMBAT, a small, phase 2 study supported by PCF, co-led by Hopkins investigators Mark Markowski, M.D., Ph.D., and Emmanuel Antonarakis, M.D., (now Director of Genitourinary Oncology at the University of Minnesota) tested the combination of BAT and immunotherapy in 45 men with metastatic castration-resistant prostate cancer (mCRPC). The men were treated with BAT in combination with nivolumab (an immunotherapy agent). “We saw an impressive clinical response rate of 40 percent,” says Markowski. “We also observed a durable benefit, lasting over a year, in a few patients who had received extensive prior therapies.” The results suggested that BAT alone has significant efficacy, while nivolumab improves responses in some patients. The combination of BAT with nivolumab was safe and well tolerated by the participants. Markowski and Antonarakis are designing a randomized Phase 3 study to compare combined BAT plus nivolumab versus standard treatments for patients with mCRPC.<br><br>In the COMBAT trial, “we treated a group of incredible men who agreed to have tumor biopsies before and after three cycles of BAT,” says Denmeade. “We are studying the heck out of these biopsies,” looking for specific biomarkers or gene mutations that might help predict who will have the deepest and longest-lasting responses. The team is also performing additional studies of the interactions between BAT and the immune system to discover how this treatment can be improved.<br><br>Could More Testosterone Be the Hidden Key to Curing Prostate Cancer? Read more in this series.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:10.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Source: <a href="https://gmail.us20.list-manage.com/track/click?u=d2dc0c23f83844a390026ba8c&id=f1daf372d5&e=4b96d7f66f" target="_blank"><span style='color:#1C557C'>https://www.pcf.org/c/bipolar-androgen-therapy-and-the-immune-system/</span></a></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=500 height=80 style='width:5.2083in;height:.8333in' id="_x0000_i1033" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/891338e5-454e-f85f-17f0-ac0df64f5367.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=400 height=66 style='width:4.1666in;height:.6875in' id="_x0000_i1032" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/3c2a310b-3e56-5348-c886-e43b189d5ce5.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><strong><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Happy Spring!</span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'><br><br>Spring is a time for new growth as the earth awakens from its winter sleep, crocuses and snow drops are peeking up in the gardens. It’s also a time for us to emerge from our winter hibernation.<br><br>During the past few months of colder weather, and shorter days, we’ve spent a lot of time indoors being sedentary and eating comfort foods…all the while packing on a few extra pounds of weight.<br> <br>It’s time to get out, get moving, and lighten up the diet a little. It’s time to put the crockpot away and pull out the salad plate and include ‘superfoods’ in your diet daily!<br> <br>What are superfoods? According to the Merriam-Webster dictionary, superfoods are “a super nutrient-dense food, loaded with vitamins, minerals, fiber, antioxidants, and/or phytonutrients”. They have specific health benefits and are a whole food in its natural state.<br> <br>And in the spring, we have some beautiful seasonal superfoods that are growing and ready to eat, and they’re mostly green. Salad greens like arugula, mustard and turnip greens, spinach, leeks, asparagus and artichokes.<br> <br>What are the big health benefits of these delicious green veggies?<br><br>They are high in antioxidants, assisting the body in fighting off free-radical damage, which can lead to cancer. Per calorie, they have more calcium than milk, and along with their high content of vitamin K, can help prevent bone loss, which leads to osteoporosis.<br>Green vegetables are powerful anti-inflammatory foods. Major health issues can be linked to chronic inflammation like cancer, heart disease, diabetes, arthritis and depression.<br><br><strong><u><span style='font-family:"Open Sans",sans-serif'>Simple Spring Salad</span></u></strong><br>Ingredients, toss together in a bowl:<br>3 cups dark leafy greens<br>2 green onions, chopped<br>1 large carrot, grated<br>1 cup cherry tomatoes, halved<br>½ can tuna<br>Dressing, whisk together and pour over salad:<br>3 TBSP olive oil<br>1 TBSP apple cider vinegar<br>1 tsp maple syrup<br>1 garlic clove, minced<br>Cheryl Wahl, RHN, Cancer Coach</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=300 height=88 style='width:3.125in;height:.9166in' id="_x0000_i1031" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/1011d422-f97a-0c6d-8eaa-31366b2ddc12.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=500 height=80 style='width:5.2083in;height:.8333in' id="_x0000_i1030" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/81546dc0-efa0-be05-873c-1183696bcba8.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><img border=0 width=400 height=160 style='width:4.1666in;height:1.6666in' id="_x0000_i1029" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/656c49f7-cb82-25de-ad7e-dfd416153139.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><strong><span style='font-size:14.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#1D567A'>Interested in nationwide support for active surveillance?</span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Join our Active Surveillance nationwide support group mailing list and you'll be the first to know about new opportunities, research, and support group meetings. </span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#838383;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;border-radius: 4px;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:black'><a href="https://gmail.us20.list-manage.com/track/click?u=d2dc0c23f83844a390026ba8c&id=f78031b310&e=4b96d7f66f" target="_blank" title="Active Surveillance Mailing List"><b><span style='font-family:"Calibri",sans-serif;color:white'>Active Surveillance Mailing List</span></b></a> </span><span style='font-size:12.0pt;font-family:"Arial",sans-serif'><o:p></o:p></span></p></td></tr></table></div></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:6.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span style='font-size:10.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'><img border=0 width=600 height=94 style='width:6.25in;height:.9791in' id="_x0000_i1028" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/d93b7516-d499-432c-bfcb-d4835c7f8df1.png"></span><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'><br>PCCN Regina is a volunteer support group for men diagnosed with prostate cancer and their families. We are a registered charity that relies on the generosity of its members, supporters and friends to fund its programs. Charitable deduction receipts for income tax purposes are issued for amounts of $10.00.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 13.5pt 13.5pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='background:#838383;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;border-radius: 5px;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:black'><a href="https://gmail.us20.list-manage.com/track/click?u=d2dc0c23f83844a390026ba8c&id=5a18623a3c&e=4b96d7f66f" target="_blank" title="Donate Today"><b><span style='font-family:"Calibri",sans-serif;color:white'>Donate Today</span></b></a> </span><span style='font-size:12.0pt;font-family:"Arial",sans-serif'><o:p></o:p></span></p></td></tr></table></div></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:18.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:14.5pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#1D567A'>Prostate Cancer Support - Regina</span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p><p class=MsoNormal style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'>Prostate Cancer Canada Network - Regina Inc. is a non-profit corporation registered in the Province of Saskatchewan and a registered charity with the Canada Revenue Agency. COVID-19 has disrupted our monthly support group meetings and our board is monitoring when we can safely resume regular meetings. The work to educate and support men and their loved ones diagnosed with prostate cancer continues.<br><br>Board members are just a phone call away for those needing to speak to someone one-on-one who has firsthand experience navigating their prostate cancer diagnosis, treatment, and symptoms. We may be able to connect you to a member who has undergone specific therapies or treatments if you want to chat about side effects or the specific treatment process.<br><br>We understand that social distancing and self-isolation can be lonely, but remember: we are all in this together and you're not alone. Cancer doesn’t stop for self-isolation or quarantine. <br><br>The safety of our members is crucial, and we will respect the decisions of our health leaders and make all adjustments as required.<br><br>Stay safe everyone.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:18.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=300 valign=top style='width:225.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='max-width:225.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#1D567A'>BOARD STRUCTURE 2022/2023</span></strong><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'><a href="mailto:info@pccnregina.ca?subject=PCS%20Regina" target="_blank"><span style='color:#1C557C'>i</span></a><a href="mailto:info@pccnregina.ca?subject=PCS%20Regina"><span style='color:#1C557C'>nfo@pccnregina.ca</span></a></span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><span style='font-size:10.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Co-Chair - Bob Terichow <br>Phone: (306) 581-9158<br><br>Co-Chair - Vacant<br><br>Treasurer - Larry Smart<br>Phone: (306) 757-4959<br><br>Secretary - Dwaine Snowfield<br>Phone: (306) 586-1403<br><br><strong><u><span style='font-family:"Open Sans",sans-serif'>Monthly Program</span></u></strong><br>Jim Odling<br>Phone: (306) 522-7590<br><br>James Froh<br>Phone: (306) 527-8290<br><br>Dwaine Snowfield<br>Phone: (306) 586-1403<br><br>Lorrie Harrison<br>Phone: (306) 545-7801<br><br>Jeff Hutton<br>Phone: (306) 533-0999<br><br><strong><u><span style='font-family:"Open Sans",sans-serif'>Out Reach Program</span></u></strong><br>James Froh<br>Phone: (306) 527-8290<br><br>Jim Odling<br>Phone: (306) 522-7590<br><br>Steve Pillipow<br>Phone: (306) 586-9345<br><br>Dwaine Snowfield<br>Phone: (306) 586-1403<br><br><strong><u><span style='font-family:"Open Sans",sans-serif'>New Members</span></u></strong><br>Jeff Hutton<br>Phone: (306) 533-0999<br><br>Chad Bakke<br>Phone: (306) 591-7275<br><br>Troy Hagen<br>Phone: (306) 535-2370</span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><u><span style='font-size:10.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Peer Sharing Volunteers</span></u></strong><span style='font-size:10.5pt;font-family:"Open Sans",sans-serif;color:#757575'><br>Lawrence Ward<br>Phone: (306) 543-8215<br><br>Stan Hanoski<br>Phone: (306) 529-1322<br><br>Lorrie Harrison <br>Phone: 306-545-7801</span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br> </span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td><td width=300 valign=top style='width:225.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='max-width:225.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal align=center style='text-align:center'><strong><span style='font-size:12.0pt;font-family:"Open Sans",sans-serif;color:#1D567A'>2022-2023 Monthly Programs</span></strong><span style='font-size:12.0pt;font-family:"Open Sans",sans-serif;color:#757575'><br><br>Monthly Programs are being developed and will be announced in future newsletters.</span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#1D567A'>2022</span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>January 13 </span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Active Surveillance Videos -<br>Bench to Bedside</span><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>February 10</span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Prostate Cancer Support Canada</span><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>March 10</span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>The use of Medical Imaging in Saskatchewan for Pca Diagnosis and Treatment</span><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>April 14</span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Androgen Deprivation Therapy (ADT)</span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>May 12</span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Medical Cannabis</span><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>June 09</span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>AGM</span><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>July - August</span></strong><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Summer Break - no scheduled programming.</span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#1D567A'>Pending for 2022-2023:</span></strong><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'><br><br> - UofR Nursing Research on Aging and Cancer<br><br>- Chemotherapy and PCa<br><br>- Wellness, Fitness, Nutrition with Paul Schwann<br><br>- Breast/Prostate Cancer Connections<br><br>- Pharmacies in relation to PCa<br><br>-PCa Resistant Therapy </span><span style='font-size:11.5pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br><br></span><span style='font-size:11.5pt;font-family:"Open Sans",sans-serif;color:#757575'><img border=0 width=250 height=138 style='width:2.6041in;height:1.4375in' id="_x0000_i1027" src="https://mcusercontent.com/d2dc0c23f83844a390026ba8c/images/7b5278f6-980d-7971-d115-bcd6bcb721f1.jpg"></span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><br><br></span><em><span style='font-size:10.5pt;font-family:"Open Sans",sans-serif;color:#757575'>Enjoy the Easter Season with</span></em><i><span style='font-size:10.5pt;font-family:"Open Sans",sans-serif;color:#757575'><br><em><span style='font-family:"Open Sans",sans-serif'>Family and Friends.</span></em></span></i><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:18.75pt 13.5pt 6.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #E0E0E0 1.0pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='mso-margin-top-alt:7.5pt;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;text-align:center;line-height:150%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><strong><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#1D567A'>Our Mailing Address:</span></strong><strong><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'> </span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:#757575'><br>PCS REGINA - PO Box 37264<br>REGINA, SK S4S 7K4<br><br>Please email us at <a href="mailto:info@pccnregina.ca" target="_blank"><span style='color:#1C557C'>info@pccnregina.ca</span></a> if you have any questions.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal align=center style='text-align:center'><span style='font-size:9.0pt;font-family:"Open Sans",sans-serif;color:#757575'> If you would like to be removed from our newsletter, please use the unsubscribe link below</span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'>.<br><br></span><span style='font-size:9.0pt;font-family:"Open Sans",sans-serif;color:#757575'>To ensure you are receiving all of our newsletters and notices,<br> please make sure <a href="mailto:pccn.regina@gmail.com"><span style='color:#1C557C'>pccn.regina@gmail.com</span></a> is in your contact list.</span><span style='font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#757575'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr><tr><td valign=top style='background:#333333;padding:33.75pt 0cm 47.25pt 0cm;background:cover;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;background-size: cover;background-position-x:50%;background-position-y:50%' id=templateFooter><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='max-width:450.0pt;border-collapse:collapse;background:#transparent none no-repeat center/cover;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;background-color:#transparent;background-size: cover;background-position-x:50%;background-position-y:50%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #505050 1.5pt;padding:0cm 0cm 0cm 0cm'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal align=center style='text-align:center;line-height:150%'><em><span style='font-size:9.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:white'>Copyright © 2022 Regina Prostate Cancer Support Group Inc. All rights reserved.</span></em><span style='font-size:9.0pt;line-height:150%;font-family:"Open Sans",sans-serif;color:white'><br><br><strong><span style='font-family:"Open Sans",sans-serif'>Our mailing address is:</span></strong><br>PCS Regina<br>PO Box 37264 <br>Regina, SK S4S 7K4 <br><br>Want to change how you receive these emails?<br>You can <a href="https://gmail.us20.list-manage.com/profile?u=d2dc0c23f83844a390026ba8c&id=5874cdcdff&e=4b96d7f66f&c=1771575682"><span style='color:white'>update your preferences</span></a> or <a href="https://gmail.us20.list-manage.com/unsubscribe?u=d2dc0c23f83844a390026ba8c&id=5874cdcdff&e=4b96d7f66f&c=1771575682"><span style='color:white'>unsubscribe from this list</span></a>.</span><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:white'> </span><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:white'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr></table></div></td></tr></table></div><p class=MsoNormal align=center style='margin-bottom:12.0pt;text-align:center'><br><br><br><br><br><o:p></o:p></p><div align=center><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:white;border-collapse:collapse;border:none' id=canspamBarWrapper><tr><td valign=top style='border:none;border-top:solid #E5E5E5 1.0pt;padding:15.0pt 0cm 15.0pt 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse' id=canspamBar><tr><td valign=top style='padding:0cm 15.0pt 3.75pt 15.0pt'><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#606060'>This email was sent to <a href="mailto:glen.tolhurst@sympatico.ca" target="_blank">glen.tolhurst@sympatico.ca</a> <br><a href="https://gmail.us20.list-manage.com/about?u=d2dc0c23f83844a390026ba8c&id=5874cdcdff&e=4b96d7f66f&c=1771575682" target="_blank"><em><span style='font-family:"Helvetica",sans-serif'>why did I get this?</span></em></a> <a href="https://gmail.us20.list-manage.com/unsubscribe?u=d2dc0c23f83844a390026ba8c&id=5874cdcdff&e=4b96d7f66f&c=1771575682">unsubscribe from this list</a> <a href="https://gmail.us20.list-manage.com/profile?u=d2dc0c23f83844a390026ba8c&id=5874cdcdff&e=4b96d7f66f&c=1771575682">update subscription preferences</a> <br>Regina Prostate Cancer Support Group Inc. · PO Box 37264 · Regina, Sk S4S 7K4 · Canada <br><br></span><a href="http://www.mailchimp.com/email-referral/?utm_source=freemium_newsletter&utm_medium=email&utm_campaign=referral_marketing&aid=d2dc0c23f83844a390026ba8c&afl=1"><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica",sans-serif;text-decoration:none'><img border=0 width=139 height=54 style='width:1.4479in;height:.5625in' id="_x0000_i1026" src="https://cdn-images.mailchimp.com/monkey_rewards/MC_MonkeyReward_15.png" alt="Email Marketing Powered by Mailchimp"></span></a><span style='font-size:8.5pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#606060'><o:p></o:p></span></p></td></tr></table></div></td></tr></table></div><p class=MsoNormal><img border=0 width=1 height=1 style='width:.0104in;height:.0104in' id="_x0000_i1025" src="https://gmail.us20.list-manage.com/track/open.php?u=d2dc0c23f83844a390026ba8c&id=1771575682&e=4b96d7f66f"><o:p></o:p></p><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p></div></body></html>